Explore a comprehensive conference talk on harnessing AI for drug discovery, delivered by Djork-Arné Clevert, Head of Machine Learning Research and Vice President at Pfizer. Delve into cutting-edge topics ranging from property prediction to molecular design, gaining valuable insights into the application of artificial intelligence in pharmaceutical research. Learn how machine learning techniques are revolutionizing the drug discovery process, potentially accelerating the development of new treatments. This 37-minute presentation, part of the Broad Institute Machine Learning in Drug Discovery Symposium 2023, offers a unique opportunity to understand the intersection of AI and pharmaceutical innovation from an industry leader.
Harnessing AI for Drug Discovery: From Property Prediction to Molecular Design
Overview
Syllabus
Broad Institute Machine Learning in Drug Discovery Symposium 2023: Djork-Arné Clevert
Taught by
Broad Institute
Related Courses
-
Decoding Biology with Data Abundance - Machine Learning in Drug Discovery
-
Automating Design of Molecules via Retrieval Augmented Generative Language Models - Broad Institute Machine Learning in Drug Discovery Symposium 2023
-
AI in Drug Discovery: What Do We Need for Being Successful?
-
AI-Driven Drug Design: Optimizing Pharmacokinetics and ADME
-
Programmable Generative Protein Design - Machine Learning in Drug Discovery
-
Computer Aided Drug Design
